Recap: Sangamo Therapeutics Q2 Earnings


Sangamo Therapeutics SGMO reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


Sangamo Therapeutics beat estimated earnings by 17.14%, reporting an EPS of $-0.29 versus an estimate of $-0.35.

Revenue was up $1.51 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 3.72% drop in the share price the next day.

Here's a look at Sangamo Therapeutics's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.31 -0.34 -0.34 -0.31
EPS Actual -0.30 -0.26 -0.33 -0.33
Revenue Estimate 27.29M 26.82M 25.19M 26.48M
Revenue Actual 28.23M 27.99M 28.56M 27.87M

To track all earnings releases for Sangamo Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!